BRIEF published on 03/10/2025 at 15:34, 1 year 1 month ago Goldman Sachs reduces its stake in EUROAPI Euronext Paris Participation Goldman Sachs Threshold Crossing EUROAPI
BRIEF published on 02/14/2025 at 12:20, 1 year 2 months ago Goldman Sachs Crosses Threshold in EUROAPI Acquisition Goldman Sachs Crossing Thresholds Shares And Voting Rights EUROAPI
BRIEF published on 02/11/2025 at 14:00, 1 year 2 months ago Goldman Sachs reduces its stake in EUROAPI Stock Market Goldman Sachs Threshold Crossing Transfer Of Shares EUROAPI
BRIEF published on 01/31/2025 at 14:28, 1 year 3 months ago Threshold Crossings by The Goldman Sachs Group, Inc. at EUROAPI Actions Financial Market Goldman Sachs Crossing Thresholds EUROAPI
BRIEF published on 12/09/2024 at 20:22, 1 year 4 months ago EUROAPI Enters a New Chapter with Leadership Changes Pharmaceuticals 2024 Outlook Leadership Change EUROAPI FOCUS-27 Plan
PRESS RELEASE published on 12/09/2024 at 20:17, 1 year 4 months ago EUROAPI moves into a new chapter with new Governance and Leadership EUROAPI enters a new chapter with new Governance and Leadership as Emmanuel Blin becomes Independent Chair of the Board and David Seignolle appointed Chief Executive Officer, maintaining full-year 2024 guidance Governance Leadership EUROAPI Emmanuel Blin David Seignolle
BRIEF published on 10/16/2024 at 07:05, 1 year 6 months ago Appointment of Olivier Falut as Financial Director of EUROAPI Appointment Financial Director EUROAPI Olivier Falut FOCUS-27 Transformation
PRESS RELEASE published on 10/16/2024 at 07:00, 1 year 6 months ago Olivier Falut appointed EUROAPI’s Chief Financial Officer Olivier Falut appointed EUROAPI's Chief Financial Officer. He brings 30 years of financial management experience in the industrial sector. EUROAPI focuses on innovative active ingredient solutions for global health Chief Financial Officer Industrial Sector EUROAPI Active Ingredient Solutions Olivier Falut
BRIEF published on 10/10/2024 at 20:43, 1 year 6 months ago EUROAPI secures financing for its FOCUS-27 plan Funding Sanofi EUROAPI Hybrid Bond FOCUS-27 Plan
PRESS RELEASE published on 10/10/2024 at 20:38, 1 year 6 months ago EUROAPI completes the financing of its FOCUS-27 plan and moves forward with its execution EUROAPI completes financing of FOCUS-27 plan, refinancing €451M Credit Facility & issuing €200M Hybrid Bond, enhancing collaboration with Sanofi Financing Partnership Sanofi EUROAPI FOCUS-27
Published on 05/01/2026 at 22:30, 21 minutes ago Integrated Rewards Achieves SOC 2 Compliance to Support Enterprise-Scale Growth Across Canada's Card-Linked Rewards Network as EQ Closes Convertible Debt Financing
Published on 05/01/2026 at 22:30, 21 minutes ago Apex Critical Metals Announces Extension of Marketing Agreement with Rumble Strip Media Inc.
Published on 05/01/2026 at 18:00, 4 hours 51 minutes ago Star Copper to Present at the Emerging Growth Conference on May 7, 2026
Published on 05/01/2026 at 15:35, 7 hours 16 minutes ago LNG Energy Group Announces Partial Revocation of Cease Trade Order and Proposed Private Placement
Published on 05/01/2026 at 19:23, 3 hours 28 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/01/2026 at 17:45, 5 hours 6 minutes ago Burkhalter Group acquires Progressio Holding GmbH and anplaq ag, Tamins (GR)
Published on 05/01/2026 at 17:21, 5 hours 29 minutes ago Fuller, Smith & Turner PLC: Total Voting Rights and Treasury Shares
Published on 04/30/2026 at 20:00, 1 day 2 hours ago AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue
Published on 04/30/2026 at 19:16, 1 day 3 hours ago AXA announces the results of its Shareholders' Meeting
Published on 04/30/2026 at 19:00, 1 day 3 hours ago Capital increase through exercise of subscription rights
Published on 04/30/2026 at 18:10, 1 day 4 hours ago Minutes of the Combined General Meeting held on April 30, 2026
